Hair loss discussion includes treatments like Minoxidil, finasteride, and RU58841. Platelet rich plasma treatment is considered expensive but cheaper than hair transplant.
The launch of Pyrilutamide as a potential hair loss treatment, with people discussing whether it is better than treatments like finasteride and minoxidil. Some participants have also discussed the risks associated with importing drugs from China.
A user who has been taking minoxidil, finasteride and nizoral for one month, asking if there is any difference in their hair loss; the responses suggest that some improvement may have been seen but it can be hard to tell with just one month of treatment.
User experienced hair growth after 1 year using Dut 0.5mg weekly, Min 2.5mg daily, and derma 1.5mm weekly. Hair became thicker, healthier, and hairline improved after adding derma rolling.
User quit minoxidil and finasteride, starting stemoxydine, dermastamp, and dermapen for hair loss. Seeks advice on alternatives, avoiding androgen disruptors and vasodilators/vasoconstrictors.
A user who experienced hair loss after switching from finasteride to dutasteride and is seeking advice whether it is an indication the treatment isn't working. Replies suggest that shedding is common at first due to dutasteride's longer half-life, but patience may be necessary before results are seen.
A user's experience with an expensive hair loss clinic that failed to produce the desired results, and advice from other users on treatments such as Minoxidil, Finasteride, and RU58841.
A user who is using a combination of oral and topical treatments, including finasteride, minoxidil, pyrilutamide, dutasteride, microneedling, and ketoconazole shampoo in order to combat hair loss. Another user gave the original poster a word of warning about overusing the ketoconazole shampoo.
A monoclonal antibody clinical trial for potential hair loss treatments in Victoria, Australia and the discussion of their efficacy. People shared information about similar drugs already on the market, speculated about potential side effects, and discussed how to spread the word about the trial.